$19.47
0.060.31%
At Close: -
$19.47
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Nurix Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
NRIX | Nurix Therapeutics | -$0.45 | -$0.64 | — | — | $30.68M | $22.89M | — | — | 07/19/2024 | Get Alert |
NRIX | Nurix Therapeutics | -$0.75 | -$0.80 | -$0.76 | 5.00% | $12.69M | $16.64M | $16.59M | -0.33% | 04/10/2024 | Get Alert |
NRIX | Nurix Therapeutics | -$0.87 | -$0.57 | -$0.77 | -35.09% | $6.78M | $22.26M | $15.16M | -31.90% | 02/15/2024 | Get Alert |
NRIX | Nurix Therapeutics | -$0.90 | -$0.76 | -$0.68 | 10.53% | $10.79M | $17.23M | $18.47M | 7.18% | 10/12/2023 | Get Alert |
NRIX | Nurix Therapeutics | -$1.01 | -$0.56 | -$0.45 | 19.64% | $11.43M | $26.21M | $30.68M | 17.04% | 07/13/2023 | Get Alert |
NRIX | Nurix Therapeutics | -$0.95 | -$0.87 | -$0.75 | 13.79% | $9.62M | $10.87M | $12.69M | 16.70% | 04/13/2023 | Get Alert |
NRIX | Nurix Therapeutics | -$0.85 | -$0.79 | -$0.87 | -10.13% | $7.40M | $17.17M | $6.78M | -60.50% | 02/09/2023 | Get Alert |
NRIX | Nurix Therapeutics | -$0.65 | -$0.98 | -$0.90 | 8.16% | $10.25M | $12.08M | $10.79M | -10.67% | 10/06/2022 | Get Alert |
NRIX | Nurix Therapeutics | -$0.60 | -$0.99 | -$1.01 | -2.02% | $7.09M | $10.50M | $11.43M | 8.88% | 07/07/2022 | Get Alert |
NRIX | Nurix Therapeutics | -$0.63 | -$0.88 | -$0.95 | -7.95% | $5.01M | $9.27M | $9.62M | 3.79% | 04/07/2022 | Get Alert |
NRIX | Nurix Therapeutics | -$0.51 | -$0.69 | -$0.85 | -23.19% | $6.69M | $13.19M | $7.40M | -43.93% | 01/27/2022 | Get Alert |
NRIX | Nurix Therapeutics | -$1.09 | -$0.62 | -$0.65 | -4.84% | $4.08M | $8.57M | $10.25M | 19.63% | 10/14/2021 | Get Alert |
NRIX | Nurix Therapeutics | — | -$0.54 | -$0.60 | -11.11% | $4.18M | $8.23M | $7.09M | -13.84% | 07/13/2021 | Get Alert |
NRIX | Nurix Therapeutics | — | -$0.46 | -$0.63 | -36.96% | — | $7.94M | $5.01M | -36.89% | 04/13/2021 | Get Alert |
NRIX | Nurix Therapeutics | -$3.55 | -$0.54 | -$0.51 | 5.56% | — | $3.94M | $6.69M | 69.77% | 02/16/2021 | Get Alert |
NRIX | Nurix Therapeutics | -$0.66 | -$0.41 | -$0.59 | -43.90% | $10.58M | $6.34M | $4.08M | -35.57% | 10/14/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-10 | $-0.76 | $-0.80 | 5.00 % |
Dec 2023 | 2024-02-15 | $-0.77 | $-0.57 | -35.1 % |
Sep 2023 | 2023-10-12 | $-0.68 | $-0.76 | 10.5 % |
Jun 2023 | 2023-07-13 | $-0.45 | $-0.56 | 19.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-04-10 | $16.59M | $16.64M | -0.33 % |
Dec 2023 | 2024-02-15 | $15.16M | $22.26M | -31.9 % |
Sep 2023 | 2023-10-12 | $18.47M | $17.23M | 7.18 % |
Jun 2023 | 2023-07-13 | $30.68M | $26.21M | 17.0 % |
Nurix Therapeutics (NRIX) is scheduled to report earnings on July 19, 2024. The last reported earnings were for reported on April 10, 2024 for Q1.
The Actual EPS was $-0.76, which beat the estimate of $-0.80.
The Actual Revenue was $16.6M, which missed the estimate of $16.6M.
Browse earnings estimates, EPS, and revenue on all stocks.